Form 8-K - Current report:
SEC Accession No. 0001070081-20-000066
Filing Date
2020-03-16
Accepted
2020-03-16 08:16:36
Documents
16
Period of Report
2020-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k31620.htm   iXBRL 8-K 41500
2 EXHIBIT 99.1 a2020-03x16marciosouza.htm EX-99.1 9209
8 a20200316marciosouzaa_image1.gif GRAPHIC 5964
  Complete submission text file 0001070081-20-000066.txt   205909

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20200311.xsd EX-101.SCH 4701
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20200311_cal.xml EX-101.CAL 640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20200311_def.xml EX-101.DEF 1490
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20200311_lab.xml EX-101.LAB 26468
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20200311_pre.xml EX-101.PRE 13685
15 EXTRACTED XBRL INSTANCE DOCUMENT a8k31620_htm.xml XML 4315
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 20715369
SIC: 2834 Pharmaceutical Preparations